As of April 2024 Curis has a market cap of $84.34 Million. This makes Curis the world's 7475th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $84.34 M | 12.24% |
2023 | $75.14 M | 41.74% |
2022 | $53.01 M | -87.84% |
2021 | $0.43 B | -39.71% |
2020 | $0.72 B | 1179.96% |
2019 | $56.51 M | 147.06% |
2018 | $22.87 M | -80.07% |
2017 | $0.11 B | -73.48% |
2016 | $0.43 B | 15.33% |
2015 | $0.37 B | 190.87% |
2014 | $0.12 B | -46.7% |
2013 | $0.24 B | -11.78% |
2012 | $0.27 B | -23.42% |
2011 | $0.35 B | 135.68% |
2010 | $0.15 B | -30.49% |
2009 | $0.21 B | 359.6% |
2008 | $47.59 M | -23.2% |
2007 | $61.97 M | -0.3% |
2006 | $62.16 M | -64.61% |
2005 | $0.17 B | -29.18% |
2004 | $0.24 B | 35.89% |
2003 | $0.18 B | 458.2% |
2002 | $32.69 M | -81.97% |
2001 | $0.18 B |
On Apr 19th, 2024 the market cap of Curis was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $147.22 B | 174,453.65% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.16 B | 117,476.86% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $0.21 B | 150.64% | ๐บ๐ธ USA |
Exelixis EXEL | $6.82 B | 7,995.31% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $2.49 B | 2,858.39% | ๐บ๐ธ USA |
Cel-Sci
CVM | $84.2 M | -0.16% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.10 B | 26.72% | ๐บ๐ธ USA |